Beacon Pediatrics LLC

Beacon Pediatrics LLC was paid $3.71M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,937	$68K
2019	22,377	$197K
2020	19,202	$612K
2021	19,075	$662K
2022	27,808	$768K
2023	30,822	$816K
2024incomplete	19,238	$583K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	31%	24,981	20,066	$1.16M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	6,262	5,337	$478K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	10%	6,135	5,491	$380K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	8.7%	4,503	4,133	$322K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	8.6%	5,432	4,552	$318K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	5.1%	2,399	2,194	$190K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.5%	2,926	2,282	$91K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.2%	2,768	2,495	$83K
90686		1.8%	4,579	4,250	$68K
96127		1.3%	11,753	9,845	$49K
96110	Developmental screening, with scoring and documentation, per standardized instrument	1.3%	4,338	2,662	$47K
99460		1.2%	785	728	$45K

79 more codes

87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.1%	2,776	$39K
92551		<1%	4,240	$37K
90670		<1%	2,705	$32K
90680		<1%	2,361	$30K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	656	$25K
90698		<1%	2,074	$24K
90633		<1%	1,752	$23K
90651		<1%	1,333	$19K
99203	Doctor's office visit, new patient (routine)	<1%	219	$18K
90697		<1%	1,083	$17K
99173		<1%	6,427	$13K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,091	$12K
99051		<1%	953	$12K
90744		<1%	950	$12K
83655		<1%	1,702	$11K
99174		<1%	2,398	$10K
90671		<1%	792	$9K
96161		<1%	3,279	$9K
90619		<1%	476	$8K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,325	$8K
87634		<1%	153	$7K
0071A		<1%	227	$7K
0072A		<1%	191	$6K
90672		<1%	337	$6K
99383		<1%	52	$5K
90710		<1%	399	$5K
90696		<1%	377	$5K
90716		<1%	368	$5K
90707		<1%	399	$4K
96160		<1%	1,592	$4K
90656		<1%	242	$4K
90480		<1%	163	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,327	$4K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	153	$3K
90734		<1%	249	$3K
99384		<1%	26	$3K
99382		<1%	45	$3K
85018		<1%	1,742	$3K
0002A		<1%	113	$2K
90621		<1%	128	$2K
90715		<1%	164	$2K
0001A		<1%	151	$2K
90677		<1%	96	$2K
0004A		<1%	45	$1K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	15	$1K
0054A		<1%	65	$1K
99050		<1%	78	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	589	$1K
99188		<1%	55	$1K
0124A		<1%	30	$1K
91318		<1%	63	$825.49
87807		<1%	225	$675.46
91320		<1%	12	$602.20
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	65	$490.00
0082A		<1%	12	$480.00
0011A		<1%	44	$440.00
81002		<1%	345	$423.17
90660		<1%	17	$331.05
90685		<1%	552	$331.05
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	50	$261.03
90688		<1%	23	$234.39
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	14,658	$216.72
0074A		<1%	16	$200.00
99499		<1%	24	$149.00
90461		<1%	8,235	$116.70
96380		<1%	15	$87.08
36416		<1%	2,182	$67.50
90473		<1%	64	$20.00
81003		<1%	12	$11.24
91307		<1%	558	$0.83
91308		<1%	93	$0.51
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	14	$0.40
91305		<1%	127	$0.37
91312		<1%	30	$0.13
0012A		0%	23	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	16	$0.00
G9920	Screening performed and negative	0%	6,368	$0.00
99072		0%	359	$0.00
91300		0%	233	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGIDEON, NANCY (MD/PRACTICE OWNER)